The FDA is getting tough on hydrocodone painkillers that have the potential for being addictive. In particular, hydrocodone dispensation by pharmacies across the United States is being strictly limited in order to prevent the rising problem of drug abuse.
In what looked to be a radical step in the right direction, the FDA has finally decided to severely curtail the sale of hydrocodone painkillers. The addiction that this drug causes is in the same class as that caused by oxycodone and morphine. So access to it had to be restricted.
Don't Miss: Incredible Pokemon Gifts
Being the highest selling analgesic in the US, the drug had all the potential for being an extremely habit-forming medication. The usage of prescription drugs to fuel addictive behavior had surpassed the sniffing of cocaine among addicts. This was a worrisome trend that had to be dealt with. Finally the FDA got the message and decided enough was enough.
Some decisions come a little late though. The Drug Enforcement Administration had warned the FDA regarding hydrocodone almost ten years ago. Yet the dilly dallying continued till the issue had spiraled out of control. Since a long time, hydrocodone had been prescribed in tandem with aspirin and acetaminophen.
This drug had been the #1 choice for getting rid of excruciating pain whether it was lumbago or dental caries or rheumatoid arthritis. Furthermore it is a hidden component of other drugs such as Vicodin. Almost making it to the #1 spot among the most abused drugs in the US, hydrocodone had become a fiendish pill of sorts.
The FDA’s decision comes as a Godsend for the health of a nation already overburdened by unnecessary medicaments. The reclassification and restriction of usage will prevent misuse in the future. And it will also limit many tragic deaths of patients from overdoses.
Buy Now: Sony PlaysStation VR In Stock Here